{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:26:55Z","timestamp":1794695215295,"version":"4.9.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,1]]},"DOI":"10.1097\/qai.0b013e3181685727","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T07:35:13Z","timestamp":1212046513000},"page":"142-148","source":"Crossref","is-referenced-by-count":94,"title":["Association of HIV Infection and HIV\/HCV Coinfection With C-Reactive Protein Levels"],"prefix":"10.1097","volume":"48","author":[{"given":"Jason S","family":"Reingold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora E","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Heymsfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis C","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Grunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis-an inflammatory disease.","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-4-20210131","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update.","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"R3-4-20210131","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1161\/01.CIR.0000148986.52696.07","article-title":"CDC\/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: laboratory tests available to assess inflammation-performance and standardization: a background paper.","volume":"110","author":"Roberts","year":"2004","journal-title":"Circulation"},{"key":"R4-4-20210131","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1161\/01.CIR.0000148981.71644.C7","article-title":"3rd, et al. CDC\/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.","volume":"110","author":"Smith","year":"2004","journal-title":"Circulation"},{"key":"R5-4-20210131","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl 6A","key":"R6-4-20210131","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1016\/j.amjmed.2004.02.006","article-title":"Inflammation and atherosclerosis: role of C-reactive protein in risk assessment.","volume":"116","author":"Libby","year":"2004","journal-title":"Am J Med"},{"key":"R7-4-20210131","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"R8-4-20210131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCULATIONAHA.104.504159","article-title":"C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study.","volume":"112","author":"Cushman","year":"2005","journal-title":"Circulation"},{"key":"R9-4-20210131","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction.","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R10-4-20210131","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/hrt.2003.018937","article-title":"Evidence for association between hepatitis C virus seropositivity and coronary artery disease.","volume":"90","author":"Vassalle","year":"2004","journal-title":"Heart"},{"key":"R11-4-20210131","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(02)07339-7","article-title":"Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening.","volume":"359","author":"Ishizaka","year":"2002","journal-title":"Lancet"},{"key":"R12-4-20210131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1253\/circj.67.26","article-title":"Association between hepatitis C virus core protein and carotid atherosclerosis.","volume":"67","author":"Ishizaka","year":"2003","journal-title":"Circ J"},{"key":"R13-4-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2004.01.010","article-title":"Hepatitis B and C virus infection and the risk of atherosclerosis in a general population.","volume":"174","author":"Volzke","year":"2004","journal-title":"Atherosclerosis"},{"key":"R14-4-20210131","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","article-title":"Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.","volume":"17","author":"Mary-Krause","year":"2003","journal-title":"AIDS"},{"key":"R15-4-20210131","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","article-title":"Coronary heart disease in HIV-infected individuals.","volume":"33","author":"Currier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-4-20210131","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1.","volume":"360","author":"Holmberg","year":"2002","journal-title":"Lancet"},{"key":"R17-4-20210131","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med"},{"key":"R18-4-20210131","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/QAD.0b013e3280118a0d","article-title":"The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals.","volume":"21","author":"Freiberg","year":"2007","journal-title":"AIDS"},{"key":"R19-4-20210131","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7326\/0003-4819-124-7-199604010-00006","article-title":"Immunopathogenic mechanisms of HIV infection.","volume":"124","author":"Fauci","year":"1996","journal-title":"Ann Intern Med"},{"key":"R20-4-20210131","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jmv.10433","article-title":"Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.","volume":"70","author":"Abbate","year":"2003","journal-title":"J Med Virol"},{"key":"R21-4-20210131","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/00002030-199610000-00006","article-title":"Inflammatory cytokines and inhibitors in HIV infection: correlation between interleukin-1 receptor antagonist and weight loss.","volume":"10","author":"Rimaniol","year":"1996","journal-title":"AIDS"},{"key":"R22-4-20210131","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00126334-200502010-00009","article-title":"Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents.","volume":"38","author":"Stephensen","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-4-20210131","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"R24-4-20210131","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults.","volume":"282","author":"Visser","year":"1999","journal-title":"JAMA"},{"key":"R25-4-20210131","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/aje\/kwj111","article-title":"The study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM): methods, design, and sample characteristics.","volume":"163","author":"Tien","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R26-4-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Fat distribution in men with HIV infection.","volume":"40","author":"Bacchetti","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-4-20210131","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1097\/QAD.0b013e3280108704","article-title":"Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.","volume":"20","author":"Hsue","year":"2006","journal-title":"AIDS"},{"issue":"Suppl","key":"R28-4-20210131","doi-asserted-by":"crossref","first-page":"68S","DOI":"10.1016\/0197-2456(87)90008-0","article-title":"Recruitment in the Coronary Artery Disease Risk Development in Young Adults (CARDIA) study.","volume":"8","author":"Hughes","year":"1987","journal-title":"Control Clin Trials"},{"key":"R29-4-20210131","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","article-title":"CARDIA: study design, recruitment, and some characteristics of the examined subjects.","volume":"41","author":"Friedman","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"R30-4-20210131","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1161\/01.CIR.0000148980.87579.5E","article-title":"CDC\/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group.","volume":"110","author":"Myers","year":"2004","journal-title":"Circulation"},{"key":"R31-4-20210131","first-page":"E249","article-title":"Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass.","volume":"275","author":"Gallagher","year":"1998","journal-title":"Am J Physiol"},{"key":"R33-4-20210131","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"R34-4-20210131","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.qai.0000159323.59250.83","article-title":"Increased cardiovascular disease risk indices in HIV-infected women.","volume":"39","author":"Dolan","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-4-20210131","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1590\/S0100-879X2005000500017","article-title":"Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients.","volume":"38","author":"Nascimento","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"R36-4-20210131","doi-asserted-by":"crossref","first-page":"39802","DOI":"10.1074\/jbc.M510391200","article-title":"Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion.","volume":"280","author":"Domitrovich","year":"2005","journal-title":"J Biol Chem"},{"key":"R37-4-20210131","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0168-8278(00)00036-2","article-title":"Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.","volume":"34","author":"Serfaty","year":"2001","journal-title":"J Hepatol"},{"key":"R38-4-20210131","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1210\/jcem.87.4.8364","article-title":"Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.","volume":"87","author":"Sesmilo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-4-20210131","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1210\/jcem.86.12.8087","article-title":"Inflammatory cardiovascular risk markers in women with hypopituitarism.","volume":"86","author":"Sesmilo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-4-20210131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200806010-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:21:52Z","timestamp":1618039312000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200806010-00004"}},"subtitle":["The Fat Redistribution and Metabolic Change in HIV Infection (FRAM) Study"],"short-title":[],"issued":{"date-parts":[[2008,6,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181685727","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6,1]]}}}